Edition:
India

Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

496.00INR
29 Apr 2016
Change (% chg)

Rs2.90 (+0.59%)
Prev Close
Rs493.10
Open
Rs493.10
Day's High
Rs499.45
Day's Low
Rs490.25
Volume
12,457
Avg. Vol
67,025
52-wk High
Rs888.00
52-wk Low
Rs480.00

Search Stocks
Ipca Laboratories Ltd. is an India-based pharmaceutical company. The Company's formulations business in India consists of 13 marketing divisions focusing on therapeutic segments, including non-steroidal anti-inflammatory drugs (NSAID), cardiovascular and anti-diabetics, anti-malarial, anti-bacterial, gastro intestinal (GI) products, cough preparations, dermatology, neuro psychiatry, urology, neutraceutical and others. The Company manufactures over 350 formulations and 80 active pharmaceutical ingredients (API). The Company also offers Disease Modifying Anti-Rheumatic Drugs treatment for rheumatoid arthritis. The Company exports its APIs to the United States, Canada, Brazil, Mexico and generic formulations to the United States, Canada and branded formulations to Panama, West Indies, Venezuela, Peru and Colombia in this sub-continent.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks